Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 15, 2024 · Filed Oct 17, 2024
An Upstream Bio director paid $2.81M out of pocket for Upstream Bio shares. 2 other people at Upstream Bio bought some too, in the same month. It was the first purchase in over a year.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$2,805,000
Shares × reported transaction price
$1M+
None in 12 months of history
Confirmed open-market purchases by the same insider in the available history
3 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
23 days before results of Nov 7, 2024
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.2% | −0.9% | −2.2% |
| 30 days | −8.2% | +0.6% | −8.8% |
| 90 days | −58.0% | +1.2% | −59.2% |
| 180 days | −67.5% | −10.1% | −57.4% |
| 365 days | −10.9% | +14.8% | −25.8% |
Past results only. Not a forecast.
Insider buying
Traded Oct 15, 2024 · filed 2 days later
An Upstream Bio director paid $2.81M out of pocket for Upstream Bio shares. 2 other people at Upstream Bio bought some too, in the same month. It was the first purchase in over a year.
Insider buying
Traded Oct 15, 2024 · filed 2 days later
An Upstream Bio director paid $11.2M out of pocket for Upstream Bio shares. 2 other people at Upstream Bio bought some too, in the same month. It was the first purchase in over a year.
Insider buying
Traded Oct 15, 2024 · filed 2 days later
An Upstream Bio director paid $11.2M out of pocket for Upstream Bio shares. 2 other people at Upstream Bio bought some too, in the same month. It was the first purchase in over a year.
ORBIMED ADVISORS LLC, Director's past purchases, 90 days after disclosure: 6 buys, median −44.0 pts vs S&P 500, beat it 2 of 6 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
